share_log

恩华药业(002262.SZ):新药NVX-408项目尚处于临床前研究阶段

Enhua Pharmaceutical (002262.SZ): The new drug NVX-408 project is still in the pre-clinical research stage

Gelonghui Finance ·  Apr 9 05:28

Gelonghui, April 9, 丨 Enhua Pharmaceutical (002262.SZ) held a performance briefing on April 8, 2024 to discuss “Why has the new drug NVX-408 not progressed?” The company replied that the company's new drug NVX-408 project is still in the pre-clinical research stage.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment